News Release - October 20th

GlaxoSmithKline celebrates 11 years as one of the 50 Best Employers in Canada

Company marks sixth consecutive year as top pharmaceutical employer.

MISSISSAUGA, ON (October 20 - 2011) – For the 11th consecutive year, GlaxoSmithKline Inc. (GSK) has been named one of the 50 Best Employers in Canada, ranking 26th, following this year’s annual AonHewitt Employee Engagement Survey. This is also the sixth successive year that GSK has been the top pharmaceutical employer, according to the results released today.

The national list was published by Maclean’s magazine in alphabetical order and La Presse are expected to publish the results in the beginning of November 2011.

“We have a keen focus on empowering and engaging our people, so to be recognized for 11 consecutive years as one of the Best Employers in Canada is very rewarding for the company,” said Paul Lucas, President and CEO, GlaxoSmithKline Inc. “We want GSK to remain a great place to work and value direct feedback from our employees. It provides insight into what GSK is doing well and identifies the areas where we, as a company, should continue to improve. “

This year’s survey highlights several key factors that contributed to GSK’s recognition as a Best Employer in Canada, including the company’s commitment to the health and well-being of its employees, leadership demonstrated by senior management, physical work environment, relationships between co-workers, and the company’s dedication to corporate social responsibility.

“The key contributors to being named among the top employers in the country are a reflection of the values we operate by,” said Mr. Lucas. “At GSK, we are committed to running our business with transparency, respect, integrity and a focus on the patient. It’s very meaningful that employees enjoy working together and are proud of the work we do in our communities.”

About GlaxoSmithKline

GlaxoSmithKline (GSK) is a leading research-based pharmaceutical company with a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better, and live longer. This mission gives GSK the purpose to develop innovative medicines, vaccines and healthcare solutions that help millions of people. GSK is a top 15 investor in Canadian research and development, contributing more than $141 million in 2010 alone. With a proud tradition of charitable and community support, GSK is designated a Caring Company by Imagine Canada. Discover more at GSK.ca.

For more information, please contact:
Corporate Communications
GlaxoSmithKline Inc. 905-819-3363

 

 

 

Bookmark and Share

View as PDF